SUN Pharmaceutical Industries Limited Oxaliplatin Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Oxaliplatin Export Records India — #3 Exporter, 113 Shipments, $3.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Oxaliplatin

India Pharmaceutical Trade Intelligence

$46.6M249 Suppliers123 CountriesHS 30049049

ExportsIndia → GERMANY21.5%India → RUSSIA13.9%

ImportsARGENTINA → India$44.5K ITALY → India$20.0K

#1 Supplier: FRESENIUS KABI #1 Buyer: FRESENIUS KABI

SUN Pharmaceutical Industries Limited — Oxaliplatin Exporter #3 | $3.6M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Oxaliplatin Exporter Profile

Indian Pharmaceutical Exporter · #3 for Oxaliplatin · $3.6M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #3 Indian exporter of Oxaliplatin with $3.6M in export value and 113 verified shipments. SUN Pharmaceutical Industries Limited holds a 7.7% market share in Oxaliplatin exports across 3 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Oxaliplatin Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Oxaliplatin export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Oxaliplatin?

Country	Value	Shipments	Share
BELGIUM	$2.1M	100	71.4%
ALGERIA	$706.5K	17	23.6%
MOROCCO	$148.6K	5	5.0%

SUN Pharmaceutical Industries Limited exports Oxaliplatin to 3 countries. The largest destination is BELGIUM accounting for 71.4% of SUN Pharmaceutical Industries Limited's Oxaliplatin shipments. These destinations reflect SUN Pharmaceutical Industries Limited's established distribution network and regulatory approvals in key markets.

Who Are the Top Buyers of Oxaliplatin from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$2.0M	94
PHARMACIE CENTRALE DES HOPITAUX	ALGERIA	$294.4K	8
PHARMACIE CENTRALE DES HOPITAUX (PC	ALGERIA	$200.0K	4
YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN	BELGIUM	$175.9K	6
PHARMACIE CENTRALE DES HOPITAUX PC	ALGERIA	$150.0K	3
MS SUN PHARMACEUTICALS MOROCCO LL	MOROCCO	$109.7K	3
HOPITAL CENTRAL DE LARMEE KOUBA	ALGERIA	$62.1K	2
SUN PHARMACEUTICALS MOROCCO LL	MOROCCO	$32.6K	1
M/S.SUN PHARMACEUTICALS MOROCCO LLC	MOROCCO	$6.3K	1

SUN Pharmaceutical Industries Limited supplies Oxaliplatin to 9 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by PHARMACIE CENTRALE DES HOPITAUX (ALGERIA) and PHARMACIE CENTRALE DES HOPITAUX (PC (ALGERIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Oxaliplatin Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
OXALIPLATINO SUN INJ200MG/40ML 1'S VL IT	$240.9K	11
OXALIPLATIN INJ 100MG/20ML 1'S VL GB PAC	$238.3K	5
OXALIPLATIN INJ 200MG/40ML 1'S VL GB PAC	$140.8K	6
OXALIPLATIN INJ 100MG/20ML 1S VL GB PAC	$137.4K	3
OXALIPLATINO SUN INJ 200MG/40ML 1'SVL ES	$106.7K	6
OXALIPLATINO SUN INJ100MG/20ML 1'S VL IT	$101.0K	6
OXIPLAT INJ 100 MG ( OXALIPLATIN 5MG/ML	$100.0K	2
OXALIPLATIN INJ 100MG/20ML 1'S VL GB (B	$100.0K	2
OXIPLAT 100 INJ OXALIPLATIN INJECTION 5MG/ML 20 ML PACK : 1 VIAL SAP CODE : 1122992 HSN CODE : 30049047	$100.0K	2
OXALIPLATIN INJ 50MG/10ML 1'S VL GB PACK	$76.9K	3

SUN Pharmaceutical Industries Limited exports 74 distinct Oxaliplatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is OXALIPLATINO SUN INJ200MG/40ML 1'S VL IT with 11 shipments worth $240.9K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Oxaliplatin Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	FRESENIUS KABI ONCOLOGY LIMITED	$16.6M	602	24	$27.6K
3	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$3.6M	113	3	$31.9K
4	ACCURE LABS PRIVATE LIMITED	$2.6M	78	2	$33.1K
2	JODAS EXPOIM PRIVATE LIMITED	$1.6M	32	1	$50.0K

SUN Pharmaceutical Industries Limited ranks #3 among 249 Indian Oxaliplatin exporters. Average shipment value of $31.9K compared to the market average of $130.9K. The closest competitors by value are FRESENIUS KABI ONCOLOGY LIMITED and ACCURE LABS PRIVATE LIMITED.

Which Indian Ports Ship Oxaliplatin Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	535	17.4%
SAHAR AIR CARGO ACC (INBOM4)	453	14.7%
DELHI AIR	436	14.2%
SAHAR AIR	410	13.3%
CHAWAPAYAL ICD (INCPR6)	110	3.6%
Bombay Air	108	3.5%
NHAVA SHEVA SEA (INNSA1)	97	3.1%
CHAWAPAYAL ICD	95	3.1%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Oxaliplatin Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Oxaliplatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 122 individual customs records matching SUN Pharmaceutical Industries Limited exporting Oxaliplatin, covering 74 formulations to 3 countries via 9 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 123+ countries, 693+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Oxaliplatin

Oxaliplatin

SUN Pharmaceutical Industries Limited — Oxaliplatin Exporter Profile

SUN Pharmaceutical Industries Limited — Oxaliplatin Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Oxaliplatin?

Who Are the Top Buyers of Oxaliplatin from SUN Pharmaceutical Industries Limited?

What Is India's Total Oxaliplatin Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Oxaliplatin Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Oxaliplatin Exporters?

What Oxaliplatin Formulations Does SUN Pharmaceutical Industries Limited Export?

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Oxaliplatin Exporters?

Which Indian Ports Ship Oxaliplatin Exports?

Oxaliplatin — Export Intelligence Video

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Oxaliplatin Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Oxaliplatin Export Data from SUN Pharmaceutical Industries Limited

Oxaliplatin Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source